MTOR and Birt-Hogg-Dube syndrome: However, it is not clear how the reported inhibition of mTOR activity upon loss of FLCN could lead to tumorigenesis, since mTOR was shown to be hyper-activated in tumors of BHD patients and mice devoid of FLCN [25].